Evidence map›Paper›PMID 36346871›Full record

ArticleNano letters2022

Magnetoplasmonics beyond Metals: Ultrahigh Sensing Performance in Transparent Conductive Oxide Nanocrystals.

Alessio Gabbani, Claudio Sangregorio, Bharat Tandon, Angshuman Nag, Massimo Gurioli, Francesco Pineider

Abstract read
In one paragraph

Article in Nano letters, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alessio GabbaniINSTM and Department of Chemistry and Industrial Chemistry, Università di Pisa, via G. Moruzzi 13, 56124Pisa, Italy.ORCID 0000-0002-4078-0254
Claudio SangregorioCNR-ICCOM, Via Madonna del Piano 10, 50019Sesto Fiorentino, FI, Italy.
Bharat TandonDepartment of Chemistry, Indian Institute of Science Education and Research (IISER), Pune411008, India.ORCID 0000-0003-1108-9859
Angshuman NagDepartment of Chemistry, Indian Institute of Science Education and Research (IISER), Pune411008, India.ORCID 0000-0003-2308-334X
Massimo GurioliDepartment of Physics and Astronomy, Università degli Studi di Firenze, via Sansone 1, 50019Sesto Fiorentino, FI, Italy.ORCID 0000-0002-6779-1041
Francesco PineiderINSTM and Department of Chemistry and Industrial Chemistry, Università di Pisa, via G. Moruzzi 13, 56124Pisa, Italy.ORCID 0000-0003-4066-4031

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Active modulation of the plasmonic response is at the forefront of today's research in nano-optics. For a fast and reversible modulation, external magnetic fields are among the most promising approaches. However, fundamental limitations of metals hamper the applicability of magnetoplasmonics in real-life active devices. While improved magnetic modulation is achievable using ferromagnetic or ferromagnetic-noble metal hybrid nanostructures, these suffer from severely broadened plasmonic response, ultimately decreasing their performance. Here we propose a paradigm shift in the choice of materials, demonstrating for the first time the outstanding magnetoplasmonic performance of transparent conductive oxide nanocrystals with plasmon resonance in the near-infrared. We report the highest magneto-optical response for a nonmagnetic plasmonic material employing F- and In-codoped CdO nanocrystals, due to the low carrier effective mass and the reduced plasmon line width. The performance of state-of-the-art ferromagnetic nanostructures in magnetoplasmonic refractometric sensing experiments are exceeded, challenging current best-in-class localized plasmon-based approaches.

Indexed as

Active PlasmonicsMagneto-opticsMagnetoplasmonicsNanocrystalsSensingTransparent Conductive Oxides

Identifiers

PMID36346871
PMCPMC9706655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.